ICD-10: G47.13

Recurrent hypersomnia

Clinical Information

Inclusion Terms

  • Kleine-Levin syndrome
  • Menstrual related hypersomnia

Additional Information

Description

Recurrent hypersomnia, classified under ICD-10-CM code G47.13, is a sleep disorder characterized by excessive daytime sleepiness and prolonged episodes of sleep that occur repeatedly over time. This condition can significantly impact an individual's daily functioning and quality of life.

Clinical Description

Definition

Recurrent hypersomnia is defined as a condition where an individual experiences recurrent episodes of excessive sleepiness, which may include prolonged sleep episodes lasting more than 24 hours. These episodes can occur multiple times within a year, leading to significant disruptions in daily activities and responsibilities.

Symptoms

The primary symptoms associated with recurrent hypersomnia include:
- Excessive Daytime Sleepiness: Individuals often feel an overwhelming need to sleep during the day, which can interfere with work, school, and social activities.
- Prolonged Sleep Episodes: Patients may sleep for extended periods, sometimes exceeding 24 hours, particularly during episodes.
- Difficulty Waking: Upon waking, individuals may feel groggy or disoriented, a phenomenon known as sleep inertia.
- Cognitive Impairment: Memory issues, difficulty concentrating, and impaired decision-making can occur due to the lack of restorative sleep.

Etiology

The exact cause of recurrent hypersomnia is not fully understood, but it may be associated with various factors, including:
- Genetic Predisposition: Family history of sleep disorders may increase the risk.
- Psychological Factors: Conditions such as depression or anxiety can contribute to hypersomnia.
- Medical Conditions: Certain neurological disorders, metabolic issues, or infections may trigger episodes.

Diagnosis

Diagnostic Criteria

To diagnose recurrent hypersomnia, healthcare providers typically consider:
- A detailed patient history, including sleep patterns and episodes.
- Sleep studies (polysomnography) to rule out other sleep disorders, such as narcolepsy or sleep apnea.
- Assessment of daytime functioning and the impact of sleepiness on daily life.

Differential Diagnosis

It is crucial to differentiate recurrent hypersomnia from other sleep disorders, such as:
- Narcolepsy: Characterized by sudden sleep attacks and cataplexy.
- Obstructive Sleep Apnea: Involves repeated interruptions in breathing during sleep, leading to excessive daytime sleepiness.
- Idiopathic Hypersomnia: Similar to recurrent hypersomnia but without identifiable causes.

Treatment

Management Strategies

Treatment for recurrent hypersomnia may include:
- Lifestyle Modifications: Encouraging regular sleep schedules, good sleep hygiene, and avoiding caffeine or alcohol before bedtime.
- Medications: Stimulants or wakefulness-promoting agents may be prescribed to help manage excessive daytime sleepiness.
- Cognitive Behavioral Therapy (CBT): This can be beneficial for addressing underlying psychological issues contributing to hypersomnia.

Prognosis

The prognosis for individuals with recurrent hypersomnia varies. While some may experience significant improvement with treatment, others may continue to have episodes throughout their lives. Ongoing management and support are essential for maintaining quality of life.

Conclusion

Recurrent hypersomnia (ICD-10 code G47.13) is a complex sleep disorder that requires careful diagnosis and management. Understanding its clinical features, potential causes, and treatment options is crucial for healthcare providers to support affected individuals effectively. If you suspect you or someone you know may be experiencing symptoms of recurrent hypersomnia, consulting a healthcare professional is essential for proper evaluation and intervention.

Clinical Information

Recurrent hypersomnia, classified under ICD-10 code G47.13, is a sleep disorder characterized by excessive daytime sleepiness and prolonged nighttime sleep episodes. This condition can significantly impact an individual's daily functioning and quality of life. Below is a detailed overview of the clinical presentation, signs, symptoms, and patient characteristics associated with recurrent hypersomnia.

Clinical Presentation

Recurrent hypersomnia is primarily marked by episodes of excessive sleepiness that can last for days or weeks, often recurring at intervals. Patients may experience a range of symptoms that can vary in intensity and duration. The clinical presentation typically includes:

  • Excessive Daytime Sleepiness (EDS): Patients often report an overwhelming need to sleep during the day, which can interfere with work, social activities, and daily responsibilities[1].
  • Prolonged Nighttime Sleep: Individuals may sleep for extended periods at night, often exceeding 10 hours, and still feel unrefreshed upon waking[1][2].
  • Sleep Attacks: Sudden episodes of sleep can occur, which may happen at inappropriate times, such as during conversations or while driving[2].

Signs and Symptoms

The symptoms of recurrent hypersomnia can be quite debilitating and may include:

  • Difficulty Waking Up: Patients often struggle to wake up in the morning and may feel groggy or disoriented upon rising[1].
  • Cognitive Impairment: Many individuals experience difficulties with concentration, memory, and decision-making, which can be attributed to the excessive sleepiness[2].
  • Mood Changes: Depression, irritability, and anxiety are common among those suffering from recurrent hypersomnia, potentially exacerbated by the impact of sleepiness on daily life[1][3].
  • Physical Symptoms: Some patients may report headaches, nausea, or other physical complaints, particularly during episodes of hypersomnia[2].

Patient Characteristics

Understanding the demographics and characteristics of patients with recurrent hypersomnia can aid in diagnosis and treatment. Key characteristics include:

  • Age: Recurrent hypersomnia can occur at any age but is often diagnosed in young adults and adolescents[3].
  • Gender: There is no significant gender predisposition, although some studies suggest a slightly higher prevalence in females[2].
  • Comorbid Conditions: Patients may have coexisting conditions such as depression, anxiety disorders, or other sleep disorders, which can complicate the clinical picture[1][3].
  • Family History: A family history of sleep disorders may be present, indicating a potential genetic component to the condition[2].

Conclusion

Recurrent hypersomnia (ICD-10 code G47.13) is a complex sleep disorder characterized by excessive daytime sleepiness and prolonged nighttime sleep. The clinical presentation includes significant cognitive and mood-related symptoms, which can severely impact a patient's quality of life. Understanding the signs, symptoms, and patient characteristics is crucial for effective diagnosis and management. If you suspect recurrent hypersomnia, it is essential to consult a healthcare professional for a comprehensive evaluation and appropriate treatment options.

Approximate Synonyms

Recurrent hypersomnia, classified under the ICD-10-CM code G47.13, is a sleep disorder characterized by excessive daytime sleepiness and prolonged sleep episodes. Understanding the alternative names and related terms for this condition can enhance clarity in both clinical and research contexts. Below are some of the key alternative names and related terms associated with G47.13.

Alternative Names for Recurrent Hypersomnia

  1. Recurrent Hypersomnia Syndrome: This term emphasizes the episodic nature of the condition, highlighting that individuals may experience recurrent episodes of excessive sleepiness.

  2. Hypersomnia of Central Origin: This phrase is often used to differentiate recurrent hypersomnia from other types of hypersomnia that may have different etiologies, such as those caused by sleep apnea or other sleep disorders.

  3. Idiopathic Hypersomnia: While idiopathic hypersomnia is a distinct diagnosis, it shares similarities with recurrent hypersomnia, particularly in terms of excessive daytime sleepiness. Some patients may be diagnosed with one or the other based on specific clinical features.

  4. Excessive Daytime Sleepiness (EDS): Although not a direct synonym, EDS is a common symptom associated with recurrent hypersomnia and is often used in clinical discussions regarding sleep disorders.

  1. Hypersomnolence: This broader term encompasses various forms of excessive sleepiness, including recurrent hypersomnia. It is often used in medical literature to describe conditions characterized by prolonged sleep and difficulty staying awake.

  2. Sleep Disorders: Recurrent hypersomnia falls under the larger category of sleep disorders, which includes a variety of conditions affecting sleep quality, duration, and timing.

  3. Central Disorders of Hypersomnolence: This classification includes disorders like recurrent hypersomnia and narcolepsy, which are characterized by excessive sleepiness due to central nervous system dysfunction.

  4. Polysomnography: This is a diagnostic tool often used to evaluate sleep disorders, including recurrent hypersomnia. It records various physiological parameters during sleep to help identify underlying issues.

  5. ICD-9 Code 327.1: In the previous ICD-9 coding system, recurrent hypersomnia was classified under this code, which may still be referenced in some clinical settings.

Conclusion

Understanding the alternative names and related terms for ICD-10 code G47.13: Recurrent hypersomnia is essential for accurate diagnosis, treatment, and communication among healthcare professionals. These terms not only facilitate better understanding of the condition but also aid in the classification and management of sleep disorders. If you have further questions or need more specific information about recurrent hypersomnia, feel free to ask!

Diagnostic Criteria

Recurrent hypersomnia, classified under the ICD-10-CM code G47.13, is characterized by episodes of excessive daytime sleepiness that occur repeatedly. To diagnose this condition, healthcare professionals typically rely on a combination of clinical criteria, patient history, and specific diagnostic tests. Below is a detailed overview of the criteria used for diagnosing recurrent hypersomnia.

Diagnostic Criteria for Recurrent Hypersomnia

1. Clinical Symptoms

  • Excessive Daytime Sleepiness: The primary symptom is persistent and excessive sleepiness during the day, which can lead to difficulties in functioning at work, school, or in social situations.
  • Recurrent Episodes: The condition is marked by recurrent episodes of hypersomnia, which can last from several days to weeks. These episodes may occur multiple times within a year.
  • Duration of Episodes: Each episode typically lasts for at least a few days, and the frequency of these episodes can vary significantly among individuals.

2. Sleep Patterns

  • Increased Sleep Duration: During episodes, individuals may sleep for extended periods, often exceeding 10 hours per night, and still feel unrefreshed upon waking.
  • Sleep Inertia: Patients often experience prolonged sleep inertia, which is the grogginess and disorientation felt upon waking from sleep.

3. Exclusion of Other Conditions

  • Rule Out Other Sleep Disorders: It is essential to exclude other sleep disorders that may cause similar symptoms, such as narcolepsy, sleep apnea, or other central disorders of hypersomnolence.
  • Medical and Psychiatric Evaluation: A thorough medical history and psychiatric evaluation are necessary to rule out other potential causes of excessive sleepiness, including depression or other medical conditions.

4. Polysomnography and Other Tests

  • Polysomnography (PSG): This overnight sleep study can help assess sleep architecture and rule out other sleep disorders. It measures various physiological parameters during sleep, including brain waves, oxygen levels, heart rate, and breathing patterns.
  • Multiple Sleep Latency Test (MSLT): This test measures how quickly a person falls asleep in a quiet environment during the day and can help confirm excessive daytime sleepiness.

5. Impact on Daily Life

  • Functional Impairment: The excessive sleepiness must cause significant impairment in social, occupational, or other important areas of functioning. This can include difficulties in maintaining employment, academic performance, or social relationships.

Conclusion

Diagnosing recurrent hypersomnia (ICD-10 code G47.13) involves a comprehensive evaluation that includes clinical symptoms, sleep patterns, exclusion of other sleep disorders, and objective testing. The combination of these criteria helps healthcare providers accurately identify the condition and differentiate it from other sleep-related issues. If you suspect you or someone you know may be experiencing symptoms of recurrent hypersomnia, it is advisable to consult a healthcare professional for a thorough assessment and appropriate management.

Treatment Guidelines

Recurrent hypersomnia, classified under ICD-10 code G47.13, is characterized by excessive daytime sleepiness and prolonged sleep episodes that can significantly impact daily functioning. Understanding the standard treatment approaches for this condition is crucial for effective management. Below, we explore the treatment modalities, including pharmacological, behavioral, and lifestyle interventions.

Overview of Recurrent Hypersomnia

Recurrent hypersomnia is often associated with conditions such as Kleine-Levin syndrome, which involves episodes of excessive sleep that can last for days or weeks. Patients may experience cognitive impairment, mood disturbances, and a general decline in quality of life during these episodes[1][2].

Pharmacological Treatments

Stimulants

Stimulant medications are commonly prescribed to manage excessive daytime sleepiness associated with recurrent hypersomnia. These include:

  • Modafinil (Provigil): This wakefulness-promoting agent is often the first-line treatment due to its efficacy and relatively favorable side effect profile[3].
  • Amphetamines: Medications such as dextroamphetamine may be used, particularly in cases where modafinil is ineffective[4].
  • Methylphenidate (Ritalin): Another stimulant that can help improve alertness and reduce sleepiness[5].

Antidepressants

In some cases, antidepressants may be beneficial, especially if the hypersomnia is linked to mood disorders. Selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants can be considered[6].

Other Medications

  • Sodium Oxybate: This medication is sometimes used in cases of severe hypersomnia, particularly when associated with narcolepsy, but its use in recurrent hypersomnia is less common[7].
  • Pitolisant: A newer medication that acts as a histamine H3 receptor antagonist, which may also be effective in promoting wakefulness[8].

Behavioral and Lifestyle Interventions

Sleep Hygiene

Implementing good sleep hygiene practices is essential for managing recurrent hypersomnia. Recommendations include:

  • Regular Sleep Schedule: Encouraging patients to maintain consistent sleep and wake times can help regulate their circadian rhythms[9].
  • Sleep Environment: Creating a comfortable and conducive sleep environment, free from disturbances, can improve sleep quality.

Cognitive Behavioral Therapy (CBT)

Cognitive Behavioral Therapy for insomnia (CBT-I) can be beneficial, particularly if the hypersomnia is exacerbated by anxiety or depression. This therapy focuses on changing negative thought patterns and behaviors related to sleep[10].

Napping Strategies

For some patients, scheduled napping may help manage excessive daytime sleepiness without disrupting nighttime sleep. Short naps (20-30 minutes) can be refreshing and improve alertness[11].

Monitoring and Follow-Up

Regular follow-up with healthcare providers is crucial to assess the effectiveness of treatment and make necessary adjustments. Patients should be monitored for side effects of medications and overall improvement in symptoms[12].

Conclusion

The management of recurrent hypersomnia (ICD-10 code G47.13) involves a multifaceted approach that includes pharmacological treatments, behavioral strategies, and lifestyle modifications. By tailoring treatment to the individual needs of patients, healthcare providers can significantly improve their quality of life and daily functioning. Continuous monitoring and adjustments to the treatment plan are essential for optimal outcomes. If symptoms persist or worsen, further evaluation may be necessary to rule out other underlying conditions.

For those experiencing recurrent hypersomnia, consulting with a sleep specialist can provide additional insights and personalized treatment options.

Related Information

Description

  • Excessive daytime sleepiness
  • Prolonged sleep episodes lasting over 24 hours
  • Difficulty waking up and feeling groggy
  • Cognitive impairment including memory issues
  • Risk associated with genetic predisposition
  • Psychological factors such as depression or anxiety
  • Medical conditions like neurological disorders

Clinical Information

  • Excessive daytime sleepiness
  • Prolonged nighttime sleep episodes
  • Sleep attacks occur suddenly
  • Difficulty waking up in the morning
  • Cognitive impairment and memory issues
  • Mood changes including depression and anxiety
  • Physical symptoms like headaches and nausea

Approximate Synonyms

  • Recurrent Hypersomnia Syndrome
  • Hypersomnia of Central Origin
  • Idiopathic Hypersomnia
  • Excessive Daytime Sleepiness (EDS)
  • Hypersomnolence
  • Sleep Disorders
  • Central Disorders of Hypersomnolence
  • Polysomnography

Diagnostic Criteria

  • Excessive daytime sleepiness persists
  • Recurrent episodes of hypersomnia occur
  • Episodes last at least a few days
  • Sleep duration exceeds 10 hours
  • Sleep inertia is prolonged
  • Other sleep disorders are ruled out
  • Polysomnography (PSG) and MSLT tests conducted
  • Significant impairment in daily functioning

Treatment Guidelines

  • Modafinil is first-line treatment for excessive daytime sleepiness
  • Stimulants improve alertness and reduce sleepiness
  • Antidepressants may be beneficial if linked to mood disorders
  • Sodium Oxybate used in severe cases, especially with narcolepsy
  • Pitolisant promotes wakefulness as histamine H3 receptor antagonist
  • Regular sleep schedule helps regulate circadian rhythms
  • Sleep environment is important for improving sleep quality
  • Cognitive Behavioral Therapy changes negative thought patterns related to sleep
  • Scheduled napping can manage excessive daytime sleepiness without disrupting nighttime sleep

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.